Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes

Authors


Correspondence: S. T. Ahmed, JDRF, 26, Broadway, 14th Floor, New York, NY 10004, USA.

E-mail: sahmed@jdrf.org

Summary

In a recent workshop organized by the JDRF focused on the ‘Identification and Utilization of Robust Biomarkers in Type1 Diabetes’, leaders in the field of type 1 diabetes (T1D)/autoimmunity and assay technology came together from academia, government and industry to assess the current state of the field, evaluate available resources/technologies and identify gaps that need to be filled for moving the field of T1D research forward. The highlights of this workshop are discussed in this paper, as well as the proposal for a larger, planned consortium effort, incorporating a JDRF Biomarker Core, to foster collaboration and accelerate progress in this critically needed area of T1D research.

Ancillary